NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
J7313 Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg HCPCS · Treatment
Classification Treatment › Injections and Infusions (nononcologic) (CMS RBCS)
First observed 2016
National scale 3,526 services · est. ▼ 21.2% YoY · 78 FFS beneficiaries (CY2024, all-Medicare estimate) — 1,787 observed fee-for-service services
Medicare paid $1.3M · est. · $380.61 avg / service, national — $680K observed FFS
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

2

Named groups billing this code
Named-group all-Medicare svcs · est.

2,440

Scaled from 1,217 observed FFS services.
FFS of Medicare

49%

Payer-mix frame
Services · year over year
Services YoY

-21.2%

All-Medicare est. · observed FFS -24.8%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~2,440 services

1,217 observed fee-for-service (50%) · ~1,223 estimated Medicare Advantage.

Billing for this code concentrates in one state — scaled by the national payer mix (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — J7313 (CY2024)
TX 1,470 MA 824 OH 773 AZ 459

Est. all-Medicare services by billing state (scaled estimate — assumes MA utilization mirrors FFS); open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$1.3M
Named-group allowed amount
$587K
Named-group Medicare payments
$937K · est.
— $468K observed FFS
Avg charge / svc
$1,100
Avg allowed / svc
$482
Avg payment / svc
$384
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$999 2 groups · avg submitted charge / service $1,230
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — each panel renders gated on the free tier.

See it in full: nuclear heart imaging (78452) in Arizona is open as a live example — every paid panel, on real data.

View the live example →
See the Platform — the full read, every number below, code baskets, and export. Notify me at launch →
Refine: group size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022  CY2021  CY2020 
# Physician group City St Specialty Providers J7313 svcs Submitted charges Avg charge Medicare $ Share of state* Phone
1 TEXAS RETINA ASSOCIATES DALLAS TX OPHTHALMOLOGY 18 685 $684,497 $999 100.0% (214) 692-6941
2 LONGWOOD EYE LLC WEST SPRINGFIELD MA OPHTHALMOLOGY 16 532 $654,360 $1,230 100.0% (413) 452-4111

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix — and the observed foundation every market figure here builds on. Market totals anchor on a labeled all-Medicare estimate scaled from that foundation, with the observed count disclosed beside it — Medicare only, never all-payer. Modeled all-payer databases project every payer statistically and typically run higher. Same market, different denominator. How the numbers reconcile →